Hyster-Yale, Inc. (HY) FY2026 earnings

Reported results

• Consolidated revenues were $827.4 million for Q3 2026 compared to $979.1 million in Q3 2025.
• GAAP operating loss was $(9.1) million for Q3 2026 compared to GAAP operating profit of $2.3 million in Q3 2025.
• Non-GAAP Adjusted Operating Loss was $(7.6) million in Q3 2026 compared to non-GAAP Adjusted Operating Profit of $3.3 million in Q3 2025.
• GAAP net loss attributable to stockholders was $(14.9) million, or $(0.83) per diluted share, in Q3 2026.
• Non-GAAP Adjusted Net Loss Attributable to Stockholders was $(13.8) million, or $(0.77) adjusted diluted loss per share, in Q3 2026.
• Non-GAAP Adjusted EBITDA was $6.0 million for the three months ended September 30, 2026, compared to $15.1 million in the prior-year period.

Guidance

• The company expects 2026 capital expenditures of $50 million to $60 million and plans to limit 2027 capital expenditures to $40 million to $50 million.
• Targeting at least $100 million of annual cost savings expected at maturity in 2029 from new operational initiatives, with implementation costs estimated to be at least $50 million.
• For the 2024 manufacturing footprint optimization, expected costs are $2 million to $5 million for the remainder of 2026 and $8 million to $10 million in 2027, with expected annualized income and cash benefits of $15 million to $20 million in 2027 and $30 million to $40 million in 2028.
• Excluding anticipated implementation costs, Q4 2026 adjusted net income is expected to return to positive levels.

Price and volatility reaction

The stock moved +5.4% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -14.4 vol points across the event (constant-maturity series — not the front-week crush).

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.